| Lipids Management |
1 |
1 |
| Cardiovascular Imaging |
0 |
0.93 |
| Cardiovascular Risk Management |
0 |
0.8 |
| Myocardial Infarction (MI) |
0 |
0.68 |
| Coronary Artery Disease (CAD) |
0 |
0.99 |
| Infarction |
0 |
0.47 |
| Coronary Artery Calcification |
0 |
0.4 |
| Atherosclerosis |
0 |
0.38 |
| Artery |
0 |
0.31 |
| California |
0 |
0.31 |
| Heart |
0 |
0.31 |
| CT Angiography |
0 |
0.98 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.97 |
| Intravascular Ultrasound |
0 |
0.22 |
| Osteoarthritis |
0 |
0.18 |
| Angiography |
0 |
0.16 |
| Body Mass Index |
0 |
0.16 |
| Calcium |
0 |
0.16 |
| Clinical Guidelines |
0 |
0.16 |
| CT Scan |
0 |
0.16 |
| Dyslipidemia |
0 |
0.16 |
| Europe |
0 |
0.16 |
| Lipoproteins |
0 |
0.95 |
| Meta-Analysis |
0 |
0.16 |
| New York |
0 |
0.16 |
| Prognosis |
0 |
0.16 |
| Statins |
0 |
0.16 |
| Stenosis |
0 |
0.16 |
| Ultrasonography |
0 |
0.16 |